Article

Fifth-generation femtosecond laser receives FDA clearance

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Capable of creating a corneal flap during the LASIK procedure in less than 10 seconds, according to the company, the laser has an inverted bevel-in side cut angle designed to ease the flap-lifting process, increase postoperative flap adhesion, and enhance the biomechanical stability of the cornea postoperatively. When customized, it also is capable of producing an elliptical flap.

Additional features of the laser, according to the company, include a higher repetition rate; tighter spot separation; lower energy; high-resolution digital video microscope; contemporary user interface, keyboard, and touch screen; and a design meant to be ergonomic.

“The . . . laser builds upon an 8-year history of innovation and more than 2 million IntraLase femtosecond procedures performed worldwide,” said AMO Chairman and Chief Executive Officer James Mazzo, who noted that the laser is part of the company’s proprietary technology suite (iLASIK).

Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute, San Diego, said, “The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy.” He observed clinical trials of the laser and served as medical monitor for the technology prior to its clearance by the FDA.

The laser may be ordered now for shipment in the United States by the third quarter of this year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.